Nanomi B.V.

Nanomi B.V. is a Netherlands-based pharmaceutical technology company focused on the development and manufacture of long-acting injectable (LAI) medicines. The company is a subsidiary of Lupin Limited, a global pharmaceutical company founded in 1968 by Dr. Desh Bandhu Gupta. Nanomi became part of the Lupin group in 2014 and serves as Lupin's centre of excellence for the development of complex injectable long-acting release medicines. At the core of Nanomi's offerings is its proprietary PrecisionSphere™ technology, a particle control technology that enables the production of medicines with uniform particle size, shape, and biological properties. This contrasts with conventional LAI technologies that produce variable particle sizes. The uniformity achieved by PrecisionSphere™ leads to improved injectability, optimized drug concentration release, and consistent and precise drug release over treatment durations ranging from weeks to months. The technology is protected by patents until 2038. Nanomi's Microsieve technology is another key platform, guaranteeing uniform particle size, shape, and biological properties, and is described as robust, scalable, and cost-effective, applicable to a wide range of pharmaceutical compounds. The company develops its own pipeline of long-acting injectable products and collaborates with partners to bring more LAI therapies to patients. In September 2025, Nanomi achieved FDA approval for its lead long-acting injectable product using PrecisionSphere™ technology, demonstrating the commercial readiness of the platform. The company offers flexible partnership models, from co-development to licensing, to help partners extend the lifecycle of their products and accelerate LAI development. Nanomi is positioned as a patient-centric company committed to developing and commercializing innovative long-acting injectables to improve health outcomes worldwide. Its mission is to push the boundaries of medicine innovation and address critical compliance challenges in the pharmaceutical industry.

Nanomi B.V. is a Dutch pharmaceutical technology company that became part of the Lupin group in 2014. Lupin Limited, founded in 1968 by Dr. Desh Bandhu Gupta, is a global pharmaceutical company. Upon joining Lupin, Nanomi was designated as the Lupin centre of excellence for the development of complex injectable long-acting release medicines. The company has focused on developing proprietary technologies for the manufacture of long-acting injectable medicines. Its Microsieve technology, developed in-house and with partners, guarantees uniform particle size, shape, and biological properties, offering unprecedented drug development potential. Nanomi has built a pipeline of products based on this technology. More recently, Nanomi introduced its PrecisionSphere™ technology, an advanced particle control technology that enables the production of medicines with uniform particle size, shape, and biological properties. This technology is protected by patents until 2038. In September 2025, Nanomi achieved FDA approval for its lead long-acting injectable product using PrecisionSphere™ technology, marking a significant milestone and proving the technology's commercial readiness. Nanomi continues to develop its own pipeline and collaborates with strategic partners to bring more long-acting injectables to patients. The company is positioned as a leader in the field of microsphere and nanoparticle manufacture and development of long-acting release medicines.

• 2025

  Nanomi achieved FDA approval for its lead long-acting injectable product using PrecisionSphere™ technology.

• 2014

  Nanomi became a member of the Lupin group as the Lupin centre of excellence for the development of complex injectable long-acting release medicines.

Leader in microsphere and nanoparticle manufacture and development of long-acting release medicines, offering proprietary particle control technology for improved injectability and precise drug release.

• Lead long-acting injectable product

  FDA-approved in September 2025, using PrecisionSphere™ technology.

1. 1Nanomi Monosphere Technologynanomi.com
2. 2Company - Nanominanomi.com
3. 3Technology - Nanominanomi.com
4. 4Partnership - Nanominanomi.com
5. 5Nanomi B.V. - Wikidatawikidata.org